Hicks Laurence 4
4 · Arch Therapeutics, Inc. · Filed Sep 8, 2023
Insider Transaction Report
Form 4
Hicks Laurence
Director
Transactions
- Purchase
Common Stock
2023-08-31$0.28/sh+10,292$2,830→ 10,292 total(indirect: Drake Partners) - Award
Warrants (right to buy)
2023-08-31+20,584→ 20,584 total(indirect: Drake Partners)Exercise: $1.00Exp: 2028-08-31→ Common Stock (20,584 underlying)
Footnotes (3)
- [F1]The Reporting Person is an owner of Drake Partners. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]The warrants are exercisable after the earlier of (A) the six-month anniversary after the date of issuance and (B) the date that a registration statement registering the shares underlying the warrants is declared effective.
- [F3]The warrants were sold as part of a unit with the shares of common stock reported in Table I, at a price of $0.275 per share of common stock and accompanying warrant to purchase two shares of common stock.